Search
IDEAYA Biosciences Inc
IDYAAdd to Watchlist
38.370USD
-0.240-0.62%
Market hours 09/18, 13:05（ET）
3.70BMarket Cap
LossP/E TTM
IDEAYA Biosciences Inc (IDYA) Stock Price Target & Forecast
Analyst Rating
Based on 15 analysts giving stock ratings to IDEAYA Biosciences Inc in the past month.
Buy
4 Strong Buy
10 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
52.385USD+39.10%
IDYA Analyst Recommendation Trends
In the current month, IDYA has received 10 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. IDYA average Analyst price target in the last month is 52.385.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
4
5
5
7
7
7
7
7
10
10
10
10
10
10
10
10
1
1
2
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15
16
17
19
19
19
19
19
IDYA Analyst Rating for Peer Comparison
Updated: Sep 17, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
1
0
28
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
argenx SE
ARGX
10
13
3
0
0
26
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Insmed Inc
INSM
7
17
0
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Ascendis Pharma A/S
ASND
10
10
0
0
0
20
Financial Forecasting
Based on analysts' estimates, IDYA EPS is projected to reach -1.174 in FY2026Q3, following reported EPS of -1.221 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.97
-0.99
-1.09
-1.17
-1.10
Actual
-0.94
-1.11
-1.22
--
--
Surprise
+2.85%
-12.31%
-11.83%
--
--
FAQs
What is IDEAYA Biosciences Inc's expected revenue for the next quarter?
IDEAYA Biosciences Inc's expected revenue is 5.71M.
What is IDEAYA Biosciences Inc's price target?
Analysts forecast that IDEAYA Biosciences Inc's price target is USD 52.38, with the highest forecast at USD 65.00 and the lowest forecast at USD 31.00.
How have IDEAYA Biosciences IncIDYA's recent earnings per share performed?
The market expectation was USD -1.22, while IDEAYA Biosciences IncIDYA's earnings per share (EPS) for the previous quarter was USD -1.11. EPS for the next quarter is expected at USD -1.17.
What is the analyst rating for IDEAYA Biosciences Inc?
Based on the ratings of IDEAYA Biosciences Inc's stock from 15 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.